Sowell Financial Services LLC Coherus Bio Sciences, Inc. Transaction History

Sowell Financial Services LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 05, 2021	SELL	$12.95 - $15.41 $984 - $1,171	-76 Closed	0 $0
Q1 2021 May 07, 2021	SELL	$14.42 - $21.39 $17,203 - $25,518	-1,193 Reduced 94.01%	76 $1,000
Q4 2020 Jan 13, 2021	BUY	$16.56 - $18.94 $6,027 - $6,894	364 Added 40.22%	1,269 $22,000
Q3 2020 Nov 12, 2020	BUY	$17.41 - $19.89 $8,356 - $9,547	480 Added 112.94%	905 $17,000
Q1 2020 May 12, 2020	BUY	$11.67 - $22.53 $4,959 - $9,575	425 New	425 $7,000

135

77.9M

40.7K

50.1K

Ticker CHRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,724,600
Market Cap $97.9M
Description
Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. T...

Get notified when there are updates to the investment portfolio of Sowell Financial Services LLC, based on Form 13F filings with the SEC.

Stay updated on Sowell Financial Services LLC with notifications on news.